Main Menu

Drug Target Discovery Team

Dr Spiros Linardopoulos's laboratory aims to identify and validate new molecular targets and to develop drugs through the process of hit generation, lead identification/optimisation and candidate selection. It also aims to identify tumour types and patient subgroups that would benefit from specific treatments. Dr Linardopoulos's programme encompasses both basic research and drug discovery components.

Team leader

Professor Spiros Linardopoulos

Professor Spiros Linardopoulos

Professor Spiros Linardopoulos is searching for gene targets for which new anticancer drugs can be developed and which identify patient subgroups that would benefit from treatment. He is a member of several professional organisations, including the Greek Chemical Society and the Hellenic Biochemical and Biophysical Society, and a key member of the Cancer Research UK Cancer Therapeutics Unit.

ORCID 0000-0002-6600-400X

Team members

Dr Konstantinos Drosopoulos

Staff Scientist

Dr Oliver Hickman

Post-doctoral Training Fellow

Mara Mandelia

PhD Student

Romana Ranftl

Higher Scientific Officer